norfloxacin has been researched along with Blind-Deaf Disorders in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Norfloxacin antibiotic was loaded into cross-linked poly(2-hydroxyethyl methacrylate) (pHEMA) gels, which were subsequently surface-modified with octadecyl isocyanate to produce a hydrophobic rate-limiting barrier controlling norfloxacin release." | 1.35 | Sustained release of antibiotic from poly(2-hydroxyethyl methacrylate) to prevent blinding infections after cataract surgery. ( Anderson, EM; Bryers, JD; Garty, S; Ma, H; Noble, ML; Ratner, BD; Shen, TT, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, EM | 1 |
| Noble, ML | 1 |
| Garty, S | 1 |
| Ma, H | 1 |
| Bryers, JD | 1 |
| Shen, TT | 1 |
| Ratner, BD | 1 |
1 other study available for norfloxacin and Blind-Deaf Disorders
| Article | Year |
|---|---|
Sustained release of antibiotic from poly(2-hydroxyethyl methacrylate) to prevent blinding infections after cataract surgery.
Topics: Anti-Bacterial Agents; Deaf-Blind Disorders; Delayed-Action Preparations; Humans; Norfloxacin; Polyh | 2009 |